.png){kind=logo}
GC Asia
Rottapharm plans debut high yield bond as step towards IPO
Rottapharm Madaus, an Italian-German pharmaceutical company, is looking to raise €400m in its debut bond issue. The planned notes are senior unsecured, have a 2019 maturity and are callable after three years.
JP Morgan is global coordinator, Banca Imi and Mediobanca joint bookrunners.
A roadshow started in London on Monday and will finish on Thursday, after visiting Frankfurt, Paris, Amsterdam and Milan.
With the proceeds of the Ba3/BB- rated notes and a new €100m bilateral loan facility, Rottapharm plans to repay ...Already a subscriber? Login
-
Latest news from Corporate Bonds
-
Second AGM motion jabs Barclays on fossil fuel support
26 Feb 2021 -
HIG Capital hires another MD for European direct lending biz
26 Feb 2021 -
Vedanta builds war chest for corporate revamp
26 Feb 2021 -
Fantasia, Sunac find demand for new bonds
26 Feb 2021 -
GlobalCapital Syndicated Loan, Leveraged Finance and Private Debt Awards 2020: the full results
26 Feb 2021
-
-
Latest news from Corporate Bonds
-
Second AGM motion jabs Barclays on fossil fuel support
26 Feb 2021 -
HIG Capital hires another MD for European direct lending biz
26 Feb 2021 -
Vedanta builds war chest for corporate revamp
26 Feb 2021 -
Fantasia, Sunac find demand for new bonds
26 Feb 2021 -
GlobalCapital Syndicated Loan, Leveraged Finance and Private Debt Awards 2020: the full results
26 Feb 2021
-
